Adaptin Bio (APTN) Amortization of Deferred Charges (2024 - 2025)
Adaptin Bio (APTN) reported Amortization of Deferred Charges of $53722.0 for Q1 2025, up 101.46% year-over-year from $26666.0 in Q1 2024, and down 50.44% sequentially from $108389.0 in Q4 2024.
Adaptin Bio (APTN) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Adaptin Bio has disclosed Amortization of Deferred Charges across 2 years of filings, most recently posting $53722.0 for Q1 2025.
- Quarterly Amortization of Deferred Charges rose 101.46% year-over-year to $53722.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $53722.0 (down 77.6% YoY) and the FY2025 annual result came in at $53722.0, down 77.6% from the prior year.
- Amortization of Deferred Charges eased to $53722.0 in Q1 2025, from $108389.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $108389.0 in Q4 2024 and bottomed at $22881.0 in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 53,722.00 |
| Mar 31, 2025 | 53,722.00 |
| Dec 31, 2024 | 108,389.00 |
| Dec 31, 2024 | 108,389.00 |
| Sep 30, 2024 | 81,853.00 |
| Sep 30, 2024 | 81,853.00 |
| Jun 30, 2024 | 22,881.00 |
| Jun 30, 2024 | 22,881.00 |
| Mar 31, 2024 | 26,666.00 |
| Mar 31, 2024 | 26,666.00 |